Bank of New York Mellon’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$933K Buy
2025
Q2
$443K Buy
2024
Q1
Sell
2023
Q4
$37.3K Hold
2023
Q3
$31K Hold
2023
Q2
$48.6K Buy
2019
Q2
Sell
2019
Q1
$149K Sell
2018
Q4
$136K Sell
2018
Q3
$320K Buy
2018
Q2
$407K Buy
2018
Q1
$315K Sell
2017
Q4
$288K Sell
2017
Q3
$444K Sell
2017
Q2
$351K Buy
2017
Q1
$331K Buy